Villaren, Jonald O.
HRN: 11-23-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
AZITHROMYCIN 500MG TABLET (TAB)
08/17/2022
08/21/2022
ORAL
500 Mg
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes